This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) rose 3.53% to $11.43 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.11% to 49,760.56 and the NASDAQ Composite Index falling 0.71% to 26,088.20.
This was the stock's third consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 44.41% short of its 52-week high of $20.56, which the company achieved on October 20th.
The stock outperformed some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. (VNDA) rose 2.39% to $6.42, Fortress Biotech Inc. (FBIO) rose 0.89% to $2.26, and Viking Therapeutics Inc. (VKTX) fell 1.26% to $31.32.
Trading volume (262,563) eclipsed its 50-day average volume of 261,494.
Data source: Dow Jones Market Data, FactSet. Data compiled May 12, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-12-26 1721ET

CRBP

LABU

SBIO

IBBQ

Corbus Pharmaceuticals Holdings Inc. (CRBP) shares increased by 3.53% to $11.43 on a mixed trading day, outperforming competitors like Vanda Pharmaceuticals and Fortress Biotech. This marks the third consecutive day of gains for Corbus, although it remains 44.41% below its 52-week high of $20.56. The trading volume was 262,563, surpassing the 50-day average of 261,494. The Dow Jones rose 0.11%, while the NASDAQ fell 0.71%.

MarketWatch Automated

Corbus Pharma

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

Direxion S&P Biotech Bull 3X

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

ALPS Medical Breakthrough

Invesco Nasdaq Biotechnology ETF

SPDR S&P Biotech

Dow Jones Industrial Average

NASDAQ Composite Index

Vanda Pharma

Fortress Biotech

Viking Therap

Factset Research

Fortress Biotech Pref Share FBIOP 9.375 15/12/22

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day